4.3 Article

Clofazimine for treatment of multidrug-resistant non-tuberculous mycobacteria

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Respiratory System

New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease

Simon F. K. Lee et al.

CURRENT OPINION IN PULMONARY MEDICINE (2019)

Article Immunology

Clinical Outcomes of Clofazimine Use for Rapidly Growing Mycobacterial Infections

George B. Carey et al.

OPEN FORUM INFECTIOUS DISEASES (2019)

Editorial Material Infectious Diseases

Clofazimine for the treatment of multidrug-resistant tuberculosis

C. Lange et al.

CLINICAL MICROBIOLOGY AND INFECTION (2019)

Review Microbiology

Mycobacterium abscessus: Environmental Bacterium Turned Clinical Nightmare

Rose C. Lopeman et al.

MICROORGANISMS (2019)

Article Microbiology

In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, China

Jingjing Luo et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Editorial Material Respiratory System

Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement

Jakko van Ingen et al.

EUROPEAN RESPIRATORY JOURNAL (2018)

Article Microbiology

Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease

Bumhee Yang et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

Article Microbiology

Rifabutin Is Active against Mycobacterium abscessus Complex

Dinah Binte Aziz et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

Review Respiratory System

Epidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria A Review

D. Rebecca Prevots et al.

CLINICS IN CHEST MEDICINE (2015)

Article Infectious Diseases

Treatment outcomes of refractory MAC pulmonary disease treated with drugs with unclear efficacy

Kyung-Wook Jo et al.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2014)

Article Infectious Diseases

High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria

Gwan-Han Shen et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)

Review Critical Care Medicine

An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

David E. Griffith et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)